Send us a text

Mel interviews Karina Sergi, MS, MFT Director, Psychedelic Therapy Training; Director, Diversity, Equity & Inclusion and Keith Heinzerling, MD Director, Treatment & Research In Psychedelics (TRIP) Center; Addiction Medicine.

We discuss psychedelic associated therapy, ketamine, DMT, Psilocybin, Hallucinogen persisting perception disorder (HPPD, Ontological shock, Psychnaughts and so much more as we continue our series on mental health treatment options

The Treatment and Research in Psychedelics clinic (TRIP) located at Pacific Neuroscience Institute. Their website:
https://www.pacificneuroscienceinstitute.org/treatment-research-in-psychedelics/

Support the show

Send us a text

Mel interviews and is himself interviewed by Sandy Newes, PhD who co-founded the Living Medicine Institute, an online community offering content and training for clinical and medical professionals interested in the legal use of ketamine to address mental health issues. She can be found on LinkedIn here.

Together they discuss Ketamine for depression and PTSD, dosing, Mels personal experience and how to get trained to safely and ethically provide and use this type of treatment.

There is discussion of mental health diseases and suicidality so please be aware of this particular content.

Support the show

Send us a text

Mel interviews the author's of the GPT Vs. Residents NEJM study. How did they do it, why did they do the study and what does it all mean for the future of medical education.

Support the show